Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Wistinghausen B, Toner K, Barkauskas DA, Jerkins LP, Kinoshita H, Chansky P, Pezzella G, Saguilig L, Hayashi RJ, Abhyankar H, Scull B, Karri V, Tanna J, Hanley P, Hermiston ML, Allen CE, Bollard CM. Wistinghausen B, et al. Blood Adv. 2024 Mar 12;8(5):1116-1127. doi: 10.1182/bloodadvances.2023010832. Blood Adv. 2024. PMID: 38163318 Free PMC article.
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
El-Mallawany NK, Alexander S, Fluchel M, Hayashi RJ, Lowe EJ, Giulino-Roth L, Wistinghausen B, Hermiston M, Allen CE; COG NHL Committee. El-Mallawany NK, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30565. doi: 10.1002/pbc.30565. Epub 2023 Jul 14. Pediatr Blood Cancer. 2023. PMID: 37449925
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.
Bielamowicz K, Dimitrion P, Abla O, Bomken S, Campbell P, Collin M, Degar B, Diamond EL, Eckstein OS, El-Mallawany N, Fluchel M, Goyal G, Henry MM, Hermiston M, Hogarty M, Jeng M, Jubran R, Lubega J, Kumar A, Ladisch S, McClain KL, Merad M, Mi QS, Parsons DW, Peckham-Gregory E, Picarsic J, Prudowsky ZD, Rollins BJ, Shaw PH, Wistinghausen B, Rodriguez-Galindo C, Allen CE; North American Consortium for Histiocytosis. Bielamowicz K, et al. Among authors: wistinghausen b. Cancer. 2024 Apr 30. doi: 10.1002/cncr.35301. Online ahead of print. Cancer. 2024. PMID: 38687639 Review.
Children's Oncology Group's 2023 blueprint for research: Young investigators.
Esbenshade AJ, Kahalley LS, Wistinghausen B, Cash T, Baertschiger RM, Zarnegar-Lumley S, Green A, Dhall G; COG Young Investigators Committee. Esbenshade AJ, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30567. doi: 10.1002/pbc.30567. Epub 2023 Jul 12. Pediatr Blood Cancer. 2023. PMID: 37438856
Implementation of a tier system for IVIG indications to address IVIG shortage at a tertiary care pediatric medical center.
Roth K, Darwish C, Keller MD, Hammer B, Ahmed-Winston S, Escalante E, Madrigal V, Patrick D, Diab Y, Grant C, Hanisch B, Kahn I, Khan S, Moudgil A, Wistinghausen B. Roth K, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2024 Apr;71(4):e30871. doi: 10.1002/pbc.30871. Epub 2024 Jan 27. Pediatr Blood Cancer. 2024. PMID: 38279890
How I approach B-lymphoblastic lymphoma in children.
Devine KJ, Fries C, Hermiston M, Wistinghausen B. Devine KJ, et al. Among authors: wistinghausen b. Pediatr Blood Cancer. 2023 Aug;70(8):e30401. doi: 10.1002/pbc.30401. Epub 2023 May 9. Pediatr Blood Cancer. 2023. PMID: 37158503
29 results